Detail Information of Genetic Polymorphisms
General Information of Drug Transporter (DT) | |||||
---|---|---|---|---|---|
DT ID | DTD0024 Transporter Info | ||||
Gene Name | SLC22A6 | ||||
Protein Name | Organic anion transporter 1 | ||||
Gene ID | |||||
UniProt ID | |||||
Genetic Polymorphisms of DT (GPD) | |||||
Genetic Polymorphism | rs11568626 | ||||
Site of GPD | chr11:62984542 (GRCh38.p12) | ||||
GPD Type | SNP | ||||
Allele(s) in dbSNP | C>A / C>G / C>T | ||||
Minor Allele Frequency | T=0.0186/93 (Global) | ||||
Allele T | Click to Show/Hide the Full List of Affected Drugs: 5 Drugs in Total | ||||
Cidofovir | Drug Info | Cytomegalovirus Infection | Correlated with the decreased the drug K(m) (compare with Allele C); Irrelevant to the increased drug toxicity risk in patients (compare with allele C) | [ 1], [ 2] | |
Tenofovir | Drug Info | HIV Infection | Correlated with the decreased the drug K(m) (compare with Allele C); Irrelevant to the increased drug toxicity risk in patients (compare with allele C) | [ 1], [ 2] | |
Methotrexate | Drug Info | Acute B-Cell Leukemia | Irrelevant to the the drug uptake (compare wuth Allele C) | [ 3] | |
Adefovir Dipivoxil | Drug Info | Hepatitis B | Correlated with the decreased the drug K(m) (compare with Allele C); Irrelevant to the increased drug toxicity risk in patients (compare with allele C) | [ 1], [ 2] | |
Aminohippurate | N.A. | Cancer | Irrelevant to the the drug uptake (compare wuth Allele C) | [ 3] | |
Genetic Polymorphism | rs11568634 | ||||
Site of GPD | chr11:62979488 (GRCh38.p12) | ||||
GPD Type | SNP | ||||
Allele(s) in dbSNP | C>T | ||||
Allele T | Click to Show/Hide the Full List of Affected Drugs: 2 Drugs in Total | ||||
Adefovir Dipivoxil | Drug Info | HBV Infection | Correlated with the decreased drug uptake (compare with Allele C) | [ 3] | |
Adefovir Dipivoxil | Drug Info | Hepatitis B | Correlated with the decreased drug uptake (compare with Allele C); Irrelevant to the drug clearance in patients (compare with Allele C); Irrelevant to the nephrotoxicity risk in patients (compare with Allele C) | [ 3], [ 5] | |
References | |||||
1 | Polymorphisms associated with renal adverse effects of antiretroviral therapy in a Southern Brazilian HIV cohort. Pharmacogenet Genomics. 2015 Nov;25(11):541-7. | ||||
2 | Functional consequences of single nucleotide polymorphisms in the human organic anion transporter hOAT1 (SLC22A6). J Pharmacol Exp Ther. 2005 Aug;314(2):923-31. | ||||
3 | Functional analysis of polymorphisms in the organic anion transporter, SLC22A6 (OAT1). Pharmacogenet Genomics. 2005 Apr;15(4):201-9. | ||||
4 | Predictors of kidney tubular dysfunction induced by adefovir treatment for chronic hepatitis B. World J Gastroenterol. 2015 Feb 21;21(7):2116-23. |
If you find any error in data or bug in web service, please kindly report it to Dr. Yin and Dr. Li.